. The primary tumouir is produced by syngeineic transplantation of the tumour cells into the femoral muscle of the host. In previous studies (Liotta et al., 1976b) , transplantation of tumour cells admixed with BCoG organisms caused a reduction in the number of spontaneous pulmoinary metastases and in the number of tumour cells entering the tumour vascular channels. Furthermore, this treatment produced a higher proportion of haematogenous tumour cells attached to macrophages. Other investigators (Eccles and Alexander, 1974; Wood and Gillespie, 1975) BCGLactivated macrophages are nonspecifically cytotoxic, in that they do not require recognition of specific antigens on the tumour cell membrane (Evans and Alexander, 1972) . It is well established that i.v.-injected macrophages sequester first in the lungs and are later released systemically to accumulate at sites of inflammation (Roser, 1970; Perper, Oronsky and Sanda, 1976) . Thus, it is reasonable to assume that at least some i.v.-infused activated macrophages could reach the site of tumour transplantation and affect the entry rate of tumour cells into the tumour vessels. To test this hypothesis, we have studied the effects of BCG-activated macrophages injected into the tail vein of tumour-bearing mice.
In our experimental procedure, activated macrophages were obtained from mice infected i.p. (Cleveland, Meltzer and Zbar, 1974) with 6 x 106 colony-forming units of BCG (Phipps TMC No. 1029) and harvested by the method of Perper et al. (1976) . Seven days following BCG infection mice were killed by cervical dislocation. The animals were exsanguinated and immediately 5 ml of Hanks' balanced salt solution with 2-5 i.u. heparin/ml were injected i.p. The abdomen was gently massaged and a small incision was made through the linea alba to remove the exudate with a Pasteur pipette. The exudate was incubated for 1 h in glass Petri dishes, after which nonadherent cells were removed by 3 washings. The yield was 1 x 106-2.8 x 107 cells/ml. By 51Cr release from tumour target cells, BCGactivated macrophages were verified to be 10 x more cytotoxic (20/1 macrophageto-target cell ratio) than a comparable number of macrophages induced by i.p. mineral oil. In Experiments A and B (see (Liotta et al., 1974 (Liotta et al., , 1976a . Briefly, the tumour vascular bed is perfused at physiological pressure until a fixed volume of blood effluent has been collected. The venous effluent tumour cells collected on a Nucleopore filter are then identified and counted. As shown in our previous studies, these effluent tumour cells represent the cells present in the tumour vascular channels at the time of perfusion. The effect of the activated macrophages on metastasis was evaluated by counting pulmonary metastases after inflating the excised lungs with 1-5 ml of neutral buffered formalin. One week after fixation, metastases were identified by both gross inspection and microscopic examination in serial sections through all lobes.
The experimental results in Table II indicate that BOG-activated macrophages injected i.v. can reduce the metastatic rate in this transplanted tumour-host system. A more significant reduction is (7) seen when the macrophages are injected earlier in the course of tumour growth. This reduction in metastatic rate occurs without significant alteration in the primary tumour size, proportion of necrosis, or vascularity. When macrophage injections are begun early, the number of tumour cells collected in the tumour venous effluent is greatly reduced. Macrophages injected directly into the tumour mass do not significantly reduce metastases. However, some foci of ulceration and necrosis were noted at the injection site.
In experiment A there is definite quantitative evidence that systemically introduced macrophages can depress entry of tumour cells into vascular channels of the primary tumour. The failure of intertumour macrophages to reduce metastases may have been due to their sequestration at the injection site, where the ratio of tumour cells to macrophages would be high.
As shown by Fidler (1974) , specifically activated macrophages injected i.v. can reduce the formation of artificial pulmonary metastases from tumour cells injected i.v. The present study uses nonspecifically activated macrophages to prevent spontaneous metastasis. Inhibition of the metastatic process by circulating macrophages may have occurred both in the lung and at the primary tumour.
